From 38a7a3785d5b00b747f33043ecd7694d9b2c9887 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Tue, 24 Mar 2026 04:35:06 +0000 Subject: [PATCH 1/3] extract: 2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70> --- ... economic restructuring since the 1980s.md | 6 ++++ ... four independent methodologies confirm.md | 6 ++++ ...h-cohort-mortality-us-life-expectancy.json | 32 +++++++++++++++++++ ...rth-cohort-mortality-us-life-expectancy.md | 13 +++++++- 4 files changed, 56 insertions(+), 1 deletion(-) create mode 100644 inbox/queue/.extraction-debug/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.json diff --git a/domains/health/Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md b/domains/health/Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md index 122ac4d33..788cb7661 100644 --- a/domains/health/Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md +++ b/domains/health/Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md @@ -36,6 +36,12 @@ OBBBA adds a second mechanism for US life expectancy decline: policy-driven cove --- +### Additional Evidence (extend) +*Source: [[2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy]] | Added: 2026-03-24* + +PNAS 2026 cohort analysis shows the deaths-of-despair framing is incomplete: post-1970 US birth cohorts show mortality deterioration not just in external causes (overdoses, suicide) but also in cardiovascular disease and cancer simultaneously. The problem is multi-causal across all three major cause categories, not primarily driven by external causes. + + Relevant Notes: - [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]] -- the US life expectancy reversal is the most dramatic empirical confirmation of this claim - healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- 75 percent of US healthcare dollars go to preventable diseases while government subsidizes the behaviors causing them diff --git a/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md b/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md index 42d2872be..5ff551fb9 100644 --- a/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md +++ b/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md @@ -67,6 +67,12 @@ Amodei's complementary factors framework explicitly identifies 'human constraint --- +### Additional Evidence (confirm) +*Source: [[2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy]] | Added: 2026-03-24* + +PNAS 2026 attributes US life expectancy stagnation to 'a complex convergence of rising chronic disease, shifting behavioral risks, and increases in certain cancers among younger adults' — explicitly identifying behavioral and social factors as the drivers of cohort-level mortality deterioration, not medical care quality. + + Relevant Notes: - [[social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem]] -- loneliness is one of the most actionable SDOH factors with clear cost signature and robust evidence - [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]] -- the 90% finding motivates SDOH intervention but the implementation gap persists diff --git a/inbox/queue/.extraction-debug/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.json b/inbox/queue/.extraction-debug/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.json new file mode 100644 index 000000000..c6357909b --- /dev/null +++ b/inbox/queue/.extraction-debug/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.json @@ -0,0 +1,32 @@ +{ + "rejected_claims": [ + { + "filename": "us-life-expectancy-stagnation-driven-by-post-1970-birth-cohort-mortality-deterioration-across-cvd-cancer-external-causes.md", + "issues": [ + "missing_attribution_extractor" + ] + }, + { + "filename": "2010-period-effect-deteriorated-mortality-across-all-adult-us-cohorts-simultaneously-indicating-systemic-environmental-shift.md", + "issues": [ + "missing_attribution_extractor" + ] + } + ], + "validation_stats": { + "total": 2, + "kept": 0, + "fixed": 2, + "rejected": 2, + "fixes_applied": [ + "us-life-expectancy-stagnation-driven-by-post-1970-birth-cohort-mortality-deterioration-across-cvd-cancer-external-causes.md:set_created:2026-03-24", + "2010-period-effect-deteriorated-mortality-across-all-adult-us-cohorts-simultaneously-indicating-systemic-environmental-shift.md:set_created:2026-03-24" + ], + "rejections": [ + "us-life-expectancy-stagnation-driven-by-post-1970-birth-cohort-mortality-deterioration-across-cvd-cancer-external-causes.md:missing_attribution_extractor", + "2010-period-effect-deteriorated-mortality-across-all-adult-us-cohorts-simultaneously-indicating-systemic-environmental-shift.md:missing_attribution_extractor" + ] + }, + "model": "anthropic/claude-sonnet-4.5", + "date": "2026-03-24" +} \ No newline at end of file diff --git a/inbox/queue/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md b/inbox/queue/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md index 4244911b8..3fa9a4450 100644 --- a/inbox/queue/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md +++ b/inbox/queue/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md @@ -7,9 +7,13 @@ date: 2026-03-10 domain: health secondary_domains: [] format: research-paper -status: unprocessed +status: enrichment priority: high tags: [life-expectancy, deaths-of-despair, birth-cohort, cardiovascular-disease, cancer, external-causes, mortality-trends, healthspan, belief-1] +processed_by: vida +processed_date: 2026-03-24 +enrichments_applied: ["Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md"] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content @@ -55,3 +59,10 @@ Coverage: News-Medical.net (March 10), UTMB newsroom (March 9), Subodh Verma MD PRIMARY CONNECTION: Belief 1 "healthspan is civilization's binding constraint" — structural confirmation WHY ARCHIVED: Direct disconfirmation target for Belief 1 in Session 12; result is that Belief 1 is CONFIRMED and STRENGTHENED, not disconfirmed EXTRACTION HINT: Extract as TWO claims: (1) post-1970 cohort mortality deterioration across CVD+cancer+external causes; (2) 2010 period-effect deteriorating all adult cohorts simultaneously — these have different causal implications + + +## Key Facts +- CDC released 2024 US life expectancy data showing 79.0 years (up 0.6 from 78.4 in 2023) +- PNAS published companion paper 'Cohort mortality forecasts indicate signs of deceleration in life expectancy gains' (doi: 10.1073/pnas.2519179122) +- Study analyzed mortality changes from 1979–2023 for all-cause mortality and three cause groups (cardiovascular disease, cancer, external causes) across cohorts born between the 1890s and 1980s +- 1950s birth cohort identified as inflection point where mortality improvements gave way to deterioration -- 2.45.2 From c43aea8c00b0a25b614e3049a32ba8b5d2457d94 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Tue, 24 Mar 2026 04:36:49 +0000 Subject: [PATCH 2/3] pipeline: archive 1 source(s) post-merge Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70> --- ...rth-cohort-mortality-us-life-expectancy.md | 57 +++++++++++++++++++ 1 file changed, 57 insertions(+) create mode 100644 inbox/archive/health/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md diff --git a/inbox/archive/health/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md b/inbox/archive/health/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md new file mode 100644 index 000000000..9ff4cf340 --- /dev/null +++ b/inbox/archive/health/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md @@ -0,0 +1,57 @@ +--- +type: source +title: "PNAS 2026: US Life Expectancy Stagnation Rooted in Post-1970 Birth Cohort Mortality Deterioration" +author: "Abrams & Bramajo et al. (UTMB researchers)" +url: https://www.pnas.org/doi/full/10.1073/pnas.2519356123 +date: 2026-03-10 +domain: health +secondary_domains: [] +format: research-paper +status: processed +priority: high +tags: [life-expectancy, deaths-of-despair, birth-cohort, cardiovascular-disease, cancer, external-causes, mortality-trends, healthspan, belief-1] +--- + +## Content + +Published in *Proceedings of the National Academy of Sciences*, March 9-10, 2026, by UTMB researchers. Using Lexis diagrams, the study analyzed mortality changes from 1979–2023 for all-cause mortality and three cause groups (cardiovascular disease, cancer, external causes) across cohorts born between the 1890s and 1980s. + +**Key findings:** +- The **1950s birth cohort** is the inflection point: general improvements in earlier cohorts gave way to deterioration in later cohorts. +- Cohorts born **since 1970** exhibit **increasing mortality in cardiovascular disease, cancer, AND external causes** compared to their predecessors — across all three cause groups simultaneously. +- A **broad period-based mortality deterioration beginning around 2010** affected nearly every living adult cohort at the time, driven primarily by cardiovascular disease mortality. +- These patterns portend **"an unprecedented longer-run stagnation, or even sustained decline, in US life expectancy."** +- Stagnating life expectancy is "not the result of a single cause but a complex convergence of rising chronic disease, shifting behavioral risks, and increases in certain cancers among younger adults." + +Context: CDC separately released 2024 life expectancy data showing US LE reached 79.0 years (up 0.6 from 78.4 in 2023) — a modest COVID/overdose mortality recovery. But the PNAS cohort analysis shows this surface improvement masks structural deterioration embedded in younger cohorts. + +Companion piece: PNAS paper "Cohort mortality forecasts indicate signs of deceleration in life expectancy gains" (doi: 10.1073/pnas.2519179122) from same period, using cohort mortality forecasts to confirm deceleration. + +Coverage: News-Medical.net (March 10), UTMB newsroom (March 9), Subodh Verma MD on X summarizing the key cohort finding. + +## Agent Notes + +**Why this matters:** This is the strongest structural confirmation of Belief 1 (healthspan as civilization's binding constraint) in the past year. It's not just deaths of despair (drug overdoses — which temporarily surged and are now recovering) — it's a cohort-level deterioration across cardiovascular disease, cancer, AND external causes in Americans born after 1970. This is multi-causal, structural, and worsening. + +**What surprised me:** The 2010 period-effect deteriorating EVERY adult cohort simultaneously. This isn't just a younger generation problem — something happened around 2010 that made ALL adult cohorts sicker. That's not a behavioral cohort story; it's a systemic environment story. This is highly relevant to the "compounding failure" framing of Belief 1. + +**What I expected but didn't find:** Evidence of a genuine reversal or plateau in deaths-of-despair as a sign that the healthspan problem is self-correcting. The CDC's +0.6 year LE improvement in 2024 might have suggested recovery. The PNAS cohort analysis shows this is surface-level optimism — the structural problem is in the cohort trajectory. + +**KB connections:** +- Directly strengthens Belief 1 ("Healthspan Is Civilization's Binding Constraint") — the compounding failure is confirmed across multiple cause categories +- Extends the deaths-of-despair framing: not just drug overdoses, but CVD and cancer also deteriorating in post-1970 cohorts +- Connects to Belief 2 (80-90% non-clinical determinants) — if this is "rising chronic disease, shifting behavioral risks, and behavioral cancers," that's entirely within the non-clinical determinant zone +- The "2010 period effect" is a potential new claim candidate: something environmental/social changed system-wide around 2010 + +**Extraction hints:** +- Primary claim: "US life expectancy stagnation is driven by a cohort-level mortality deterioration in Americans born after 1970 spanning CVD, cancer, and external causes — not a single-cause problem" +- Secondary claim: "A period-based mortality deterioration beginning around 2010 affected nearly every adult US cohort simultaneously, suggesting systemic environmental/behavioral causes beyond cohort effects" +- Belief 1 update candidate: temporal language should shift from "binding constraint" to "worsening binding constraint with compounding cohort dynamics" +- Counter-note: CDC 2024 shows +0.6 LE recovery — should be noted as COVID/overdose surface recovery, not structural improvement + +**Context:** UTMB = University of Texas Medical Branch. Lead researchers Abrams and Bramajo. Independently confirmed by PNAS companion paper. This is peer-reviewed, large-n historical analysis — highest quality evidence for longitudinal claims. + +## Curator Notes +PRIMARY CONNECTION: Belief 1 "healthspan is civilization's binding constraint" — structural confirmation +WHY ARCHIVED: Direct disconfirmation target for Belief 1 in Session 12; result is that Belief 1 is CONFIRMED and STRENGTHENED, not disconfirmed +EXTRACTION HINT: Extract as TWO claims: (1) post-1970 cohort mortality deterioration across CVD+cancer+external causes; (2) 2010 period-effect deteriorating all adult cohorts simultaneously — these have different causal implications -- 2.45.2 From c4fa000f1246828c67dc9c06790ec887a73fdc04 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Tue, 24 Mar 2026 04:36:59 +0000 Subject: [PATCH 3/3] extract: 2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70> --- ...of US physicians daily within two years.md | 6 +++++ ...t govern continuously learning software.md | 6 +++++ ...ce-uk-dtac-nice-esf-governance-review.json | 24 +++++++++++++++++++ ...ence-uk-dtac-nice-esf-governance-review.md | 14 ++++++++++- 4 files changed, 49 insertions(+), 1 deletion(-) create mode 100644 inbox/queue/.extraction-debug/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.json diff --git a/domains/health/OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years.md b/domains/health/OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years.md index 0f8b46653..8043e9133 100644 --- a/domains/health/OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years.md +++ b/domains/health/OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years.md @@ -46,6 +46,12 @@ ARISE report reframes OpenEvidence adoption as shadow-IT workaround behavior rat Sutter Health (3.3M patients, ~12,000 physicians) integrated OpenEvidence into Epic EHR workflows in February 2026, marking the first major health-system-wide EHR embedding. This shifts OpenEvidence from standalone app to in-workflow clinical tool, institutionalizing what ARISE identified as physicians bypassing institutional IT governance. +### Additional Evidence (extend) +*Source: [[2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review]] | Added: 2026-03-24* + +iatroX reports OE has 'signalled plans for global expansion as a key 2026 and beyond initiative' with UK, Canada, Australia identified as 'English-first markets with lower regulatory barriers.' However, iatroX notes this perception may be inaccurate for UK: NHS requires DTAC + MHRA Class 1 for formal deployment. OE's characterization of UK as having 'lower regulatory barriers' relative to US may be a strategic misjudgment—UK NHS has MORE formal digital health procurement governance than US (no federal equivalent to DTAC). + + diff --git a/domains/health/healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software.md b/domains/health/healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software.md index d388a38fe..921220ab2 100644 --- a/domains/health/healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software.md +++ b/domains/health/healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software.md @@ -19,6 +19,12 @@ The AI payment problem compounds the regulatory gap. No payer currently reimburs --- +### Additional Evidence (extend) +*Source: [[2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review]] | Added: 2026-03-24* + +UK NHS governance provides a contrasting model: DTAC (Digital Technology Assessment Criteria) + MHRA Class 1 registration + NICE Evidence Standards Framework creates a multi-layer assessment specifically for digital health tools. NHS England launched a supplier registry in January 2026 with 19 registered ambient voice transcription suppliers, all DTAC-compliant. This demonstrates an alternative regulatory approach to AI clinical tools that is more comprehensive than FDA's device-focused model. + + Relevant Notes: - [[the FDA now separates wellness devices from medical devices based on claims not sensor technology enabling health insights without full medical device classification]] -- the FDA has already created flexibility for wellness devices; clinical AI needs a parallel regulatory innovation - [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- AI payment gaps may accelerate VBC adoption by making fee-for-service untenable for AI-enabled care diff --git a/inbox/queue/.extraction-debug/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.json b/inbox/queue/.extraction-debug/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.json new file mode 100644 index 000000000..e3881dc00 --- /dev/null +++ b/inbox/queue/.extraction-debug/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.json @@ -0,0 +1,24 @@ +{ + "rejected_claims": [ + { + "filename": "openevidence-us-corpus-creates-uk-clinical-safety-risk-through-guideline-mismatch.md", + "issues": [ + "missing_attribution_extractor" + ] + } + ], + "validation_stats": { + "total": 1, + "kept": 0, + "fixed": 1, + "rejected": 1, + "fixes_applied": [ + "openevidence-us-corpus-creates-uk-clinical-safety-risk-through-guideline-mismatch.md:set_created:2026-03-24" + ], + "rejections": [ + "openevidence-us-corpus-creates-uk-clinical-safety-risk-through-guideline-mismatch.md:missing_attribution_extractor" + ] + }, + "model": "anthropic/claude-sonnet-4.5", + "date": "2026-03-24" +} \ No newline at end of file diff --git a/inbox/queue/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.md b/inbox/queue/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.md index 8019692f1..c736ff67f 100644 --- a/inbox/queue/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.md +++ b/inbox/queue/2026-03-20-iatrox-openevidence-uk-dtac-nice-esf-governance-review.md @@ -7,9 +7,13 @@ date: 2026-03-20 domain: health secondary_domains: [] format: blog-analysis -status: unprocessed +status: enrichment priority: medium tags: [openevidence, nhs-dtac, nice-esf, uk-healthcare, clinical-ai-safety, belief-5, regulatory-compliance, corpus-bias] +processed_by: vida +processed_date: 2026-03-24 +enrichments_applied: ["OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years.md", "healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software.md"] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content @@ -70,3 +74,11 @@ iatroX Clinical AI Insights is a UK-focused clinical AI review publication that PRIMARY CONNECTION: OE model opacity thread (Sessions 8-11) — extended to UK clinical corpus mismatch WHY ARCHIVED: Provides a previously undocumented clinical risk category for OE in non-US markets: guideline mismatch, not just LLM failure modes EXTRACTION HINT: Extract as "OE UK deployment risk" claim, keeping scope to UK clinical practice (NICE vs. AHA corpus misalignment); link to DTAC absence finding + + +## Key Facts +- NHS England launched ambient scribing supplier registry in January 2026 with 19 registered vendors +- NHS England's April 2025 ambient scribing guidance requires clinical safety case (DCB0160), DPIA, mandatory human verification +- DTAC V2 deadline was April 6, 2026 +- OpenEvidence Visits launched August 2025 as hybrid documentation+CDSS tool +- UK-native DTAC-compliant alternatives include: iatroX, Medwise AI, Praktiki, Pathway -- 2.45.2